Philip Santangelo used mRNA and CRISPR technology to target and eliminate the dengue mosquito-borne virus, which currently has no effective antiviral treatment.

By: Jerry Grillo (jerry.grillo@ibb.gatech.edu)
Wallace H. Coulter Department of Biomedical Engineering
Blank Space (small)
(text and background only visible when logged in)